Professor Ranjit Manchanda

Profile

I was appointed as Professor of Gynaecological Oncology at Wolfson Institute of Population Health, QMUL in Sep 2019. I worked at Barts Cancer Institute, QMUL as a Clinical Senior Lecturer from June 2015. I have worked as a consultant Gynaecological Oncologist at Barts Health NHS Trust from June 2015. From 2014- 2015 I worked as a Locum Consultant Gynaecological Oncologist at Barts Health and Honorary Senior Lecturer at University College London, UK. I completed a PhD in gynaecological oncology at UCL, followed by a NIHR ACL Fellowship and subspecialty training in gynaecological oncology from UCLH and Bart's Hospital.

Research:

My research is focused on Targeted Precision Prevention. This includes population-based genetic testing, mainstreaming genetic testing and precision medicine approaches for risk prediction, population stratification, targeted screening, cancer prevention (including surgical) and management of familial gynaecological cancer. I have a keen research interest in health economic issues related to these areas.

I am Chief Investigator (CI) on PROTECT (PROTECT: Population based Germline testing for Early detection and Cancer Prevention); PROTECTOR (Preventing Ovarian Cancer through early Excision of Tubes and late Ovarian Removal) trial; DETECT-2 (Direct to Patient testing at Cancer diagnosis for Precision Prevention) study; PROMISE Feasibility study (pilot general population testing and personalised ovarian cancer risk prediction study); SIGNPOST (SystematIc GeNetic testing for Personalised Ovarian cancer Therapy) study and RRESDO (study evaluating attitudes towards early salpingectomy) studies; Co-PI of GCaPPS trial (population based BRCA testing RCT in the Jewish population); Co-Lead for UKCOGS (UK COVID and Gynaecological Cancer Study); Co-lead for SURAKSHA- South Asian Breast Cancer Risk Prediction, Genetic testing & Health Management programme. I have worked on ovarian cancer screening trials (UKCTOCS, UKFOCSS and ALDO).

Research

Publications

• Philpott S, Raikou M, Manchanda R et al. (2023). The avoiding late diagnosis of ovarian cancer (ALDO) project; A pilot national surveillance programme for women with pathogenic germline variants in BRCA1 and BRCA2. nameOfConference

  
  

  DOI: 10.1136/jmg-2022-108741

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/82478
• Laforêts F, Kotantaki P, Malacrida B et al. (2023). Semi-supervised analysis of myeloid and T cell behavior in ex vivo ovarian tumor slices reveals changes in cell motility after treatments. nameOfConference

  
  

  DOI: 10.1016/j.isci.2023.106514

  
  

  QMRO: qmroHref
• Elorbany S, Berlato C, Carnevalli L et al. (2023). Abstract LB195: Immunotherapies that repolarize macrophages and CD4 T cells enhance the effect of chemotherapy in high-grade serous ovarian cancer. nameOfConference

  
  

  DOI: 10.1158/1538-7445.am2023-lb195

  
  

  QMRO: qmroHref
• Malacrida B, Elorbany S, Maniati E et al. (2023). Abstract 4551: Reconstructing the metastatic tumor microenvironment of high grade serous ovarian cancer: understanding the contribution of malignant cells. nameOfConference

  
  

  DOI: 10.1158/1538-7445.am2023-4551

  
  

  QMRO: qmroHref
• Laforets F, Kotantaki P, Malacrida B et al. (2023). Abstract 5913: Semi-supervised analysis of myeloid and T cell behavior in ex vivo ovarian tumor slices reveals changes in cell motility after treatments. nameOfConference

  
  

  DOI: 10.1158/1538-7445.am2023-5913

  
  

  QMRO: qmroHref
• Kotantaki P, Laforêts F, Maniati E et al. (2023). Abstract 5957: Chemotherapy-induced extracellular matrix remodeling in HGSOC. nameOfConference

  
  

  DOI: 10.1158/1538-7445.am2023-5957

  
  

  QMRO: qmroHref
• Lacaze P, Manchanda R, Green RC (2023). Prioritizing the detection of rare pathogenic variants in population screening. nameOfConference

  
  

  DOI: 10.1038/s41576-022-00571-9

  
  

  QMRO: qmroHref
• Gaba F, Blyuss O, Tan A et al. (2023). Breast Cancer Risk and Breast-Cancer-Specific Mortality following Risk-Reducing Salpingo-Oophorectomy in BRCA Carriers: A Systematic Review and Meta-Analysis. nameOfConference

  
  

  DOI: 10.3390/cancers15051625

  
  

  QMRO: qmroHref
• Oxley S, Wei X, Sideris M et al. (2023). Cost-Effectiveness of Genetic Testing Strategies for Breast Cancer. nameOfConference

  
  

  DOI: 10.1007/978-981-19-7630-8_8

  
  

  QMRO: qmroHref
• Oxley S, Kalra A, Sideris M et al. (2023). Impact of Multiple COVID-19 Waves on Gynaecological Cancer Services in the UK. nameOfConference

  
  

  DOI: 10.3390/cancers15041273

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/84629
• Bizzarri N, Dostálek L, Van Lonkhuijzen LRCW et al. (2023). Association of Hospital Surgical Volume With Survival in Early-Stage Cervical Cancer Treated With Radical Hysterectomy. nameOfConference

  
  

  DOI: 10.1097/AOG.0000000000005026

  
  

  QMRO: qmroHref
• Morgan RD, Clamp AR, Barnes BM et al. (2023). Homologous recombination deficiency in newly diagnosed FIGO stage III/IV high-grade epithelial ovarian cancer: A multi-national observational study. nameOfConference

  
  

  DOI: 10.1136/ijgc-2022-004211

  
  

  QMRO: qmroHref
• Wei X, Oxley S, Sideris M et al. (2023). Quality of life after risk-reducing surgery for breast and ovarian cancer prevention: a systematic review and meta-analysis. nameOfConference

  
  

  DOI: 10.1016/j.ajog.2023.03.045

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/85819
• Yong N, Cooper N, Yorke S et al. (2023). Variation in outcome reporting in studies of fertility-sparing surgery for cervical cancer: A systematic review. nameOfConference

  
  

  DOI: 10.1111/1471-0528.17342

  
  

  QMRO: qmroHref
• Wei X, Oxley S, Sideris M et al. (2022). Cost-Effectiveness of Risk-Reducing Surgery for Breast and Ovarian Cancer Prevention: A Systematic Review. nameOfConference

  
  

  DOI: 10.3390/cancers14246117

  
  

  QMRO: qmroHref
• Oxley S, Xiong R, Wei X et al. (2022). Quality of Life after Risk-Reducing Hysterectomy for Endometrial Cancer Prevention: A Systematic Review. nameOfConference

  
  

  DOI: 10.3390/cancers14235832

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/83022
• Hanson H, Kulkarni A, Loong L et al. (2022). UK consensus recommendations for clinical management of cancer risk for women with germline pathogenic variants in cancer predisposition genes: RAD51C, RAD51D, BRIP1 and PALB2. nameOfConference

  
  

  DOI: 10.1136/jmg-2022-108898

  
  

  QMRO: qmroHref
• Gaba F, Ash K, Blyuss O et al. (2022). Patient outcomes following interval and delayed cytoreductive surgery in advanced ovarian cancer: protocol for a multicenter, international, cohort study (Global Gynaecological Oncology Surgical Outcomes Collaborative). nameOfConference

  
  

  DOI: 10.1136/ijgc-2022-004101

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/82509
• Wei X, Oxley S, Sideris M et al. (2022). 2022-RA-1270-ESGO Quality of Life after risk-reducing surgery for breast and ovarian cancer prevention: a systematic review and meta-analysis. Prevention of gynaecologic cancer

  
  

  DOI: 10.1136/ijgc-2022-esgo.822

  
  

  QMRO: qmroHref
• Wei X, Oxley S, Sideris M et al. (2022). 2022-RA-1272-ESGO Cost-effectiveness of risk-reducing surgery for breast and ovarian cancer prevention: a systematic review. Prevention of gynaecologic cancer

  
  

  DOI: 10.1136/ijgc-2022-esgo.823

  
  

  QMRO: qmroHref
• Gaba F, Blyuss O, Tan A et al. (2022). 2022-RA-1390-ESGO Meta-analysis of breast cancer risk and breast cancer specific mortality following risk reducing salpingo-oophorectomy in BRCA carriers. Prevention of gynaecologic cancer

  
  

  DOI: 10.1136/ijgc-2022-esgo.825

  
  

  QMRO: qmroHref
• Yong N, Cooper N, Yorke S et al. (2022). 2022-RA-1407-ESGO Variation in outcome reporting in studies of fertility sparing surgery for cervical cancer: a systematic review. Fertility/Pregnancy

  
  

  DOI: 10.1136/ijgc-2022-esgo.384

  
  

  QMRO: qmroHref
• Sobocan M, Chandrasekaran D, Sideris M et al. (2022). 2022-RA-1443-ESGO Patient decision aids in genetic testing for women with ovarian cancer. Vaginal and vulvar cancer

  
  

  DOI: 10.1136/ijgc-2022-esgo.1000

  
  

  QMRO: qmroHref
• Burnell M, Gaba F, Sideris M et al. (2022). 2022-RA-1465-ESGO Randomised trial of population based BRCA testing in Ashkenazi Jews: long term secondary lifestyle behavioural outcomes. Quality of life after treatment

  
  

  DOI: 10.1136/ijgc-2022-esgo.861

  
  

  QMRO: qmroHref
• Van der Kolk WL, Van der Zee AGJ, Slomovitz BM et al. (2022). Unilateral inguinofemoral lymphadenectomy in patients with early-stage vulvar squamous cell carcinoma and a unilateral metastatic sentinel lymph node is safe. nameOfConference

  
  

  DOI: 10.1016/j.ygyno.2022.07.017

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/82483
• Cummins C, Kumar S, Long J et al. (2022). Investigating the Impact of Ultra-Radical Surgery on Survival in Advanced Ovarian Cancer Using Population-Based Data in a Multicentre UK Study. nameOfConference

  
  

  DOI: 10.3390/cancers14184362

  
  

  QMRO: qmroHref
• Sun L, Wei X, Manchanda R et al. (2022). Using Genetic Testing at Cancer Diagnosis for Breast Cancer Control. nameOfConference

  
  

  DOI: 10.46234/ccdcw2022.148

  
  

  QMRO: qmroHref
• Manchanda R, Sideris M (2022). Population based genetic testing for cancer susceptibility genes: quo vadis. nameOfConference

  
  

  DOI: 10.1111/1471-0528.17283

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/80204
• Torr B, Jones C, Choi S et al. (2022). A digital pathway for genetic testing in UK NHS patients with cancer: BRCA-DIRECT randomised study internal pilot. nameOfConference

  
  

  DOI: 10.1136/jmg-2022-108655

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/79662
• Burnell M, Gaba F, Sobocan M et al. (2022). Randomised trial of population based BRCA testing in Ashkenazi Jews: Long term secondary lifestyle behavioural outcomes. nameOfConference

  
  

  DOI: 10.1111/1471-0528.17253

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/79318
• Lee A, Yang X, Tyrer J et al. (2022). Comprehensive epithelial tubo-ovarian cancer risk prediction model incorporating genetic and epidemiological risk factors. nameOfConference

  
  

  DOI: 10.1136/jmedgenet-2021-107904

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/72638
• Tindale LC, Zhantuyakova A, Lam S et al. (2022). Gynecologic Cancer Risk and Genetics: Informing an Ideal Model of Gynecologic Cancer Prevention. nameOfConference

  
  

  DOI: 10.3390/curroncol29070368

  
  

  QMRO: qmroHref
• Sundar S, Cummins C, Kumar S et al. (2022). Quality of life from cytoreductive surgery in advanced ovarian cancer: Investigating the association between disease burden and surgical complexity in the international, prospective, SOCQER-2 cohort study. nameOfConference

  
  

  DOI: 10.1111/1471-0528.17041

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/75658
• Barrett JE, Jones A, Evans I et al. (2022). The DNA methylome of cervical cells can predict the presence of ovarian cancer. nameOfConference

  
  

  DOI: 10.1038/s41467-021-26615-y

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/76607
• Kalra A, Sobocan M, Reisel D et al. (2022). Role of Genetics in Gynaecological Cancers. nameOfConference

  
  

  DOI: 10.1007/978-3-030-94110-9_17

  
  

  QMRO: qmroHref
• Reisel D, Burnell M, Side L et al. (2022). Jewish cultural and religious factors and uptake of population-based BRCA testing across denominations: a cohort study. nameOfConference

  
  

  DOI: 10.1111/1471-0528.16994

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/75198
• Gaba F, Oxley S, Liu X et al. (2022). Unselected Population Genetic Testing for Personalised Ovarian Cancer Risk Prediction: A Qualitative Study Using Semi-Structured Interviews. nameOfConference

  
  

  DOI: 10.3390/diagnostics12051028

  
  

  QMRO: qmroHref
• Sun L, Cui B, Wei X et al. (2022). Cost-Effectiveness of Genetic Testing for All Women Diagnosed with Breast Cancer in China. nameOfConference

  
  

  DOI: 10.3390/cancers14071839

  
  

  QMRO: qmroHref
• Taylor A, Sundar SS, Bowen R et al. (2022). British Gynaecological Cancer Society Recommendations for Women With Gynecological Cancer Who Received Non-standard Care During the COVID-19 Pandemic. nameOfConference

  
  

  DOI: 10.1097/01.ogx.0000822432.56370.10

  
  

  QMRO: qmroHref
• Taylor A, Sundar SS, Bowen R et al. (2022). British Gynaecological Cancer Society Recommendations for Women with Gynecological Cancer Who Received Non-standard Care during the COVID-19 Pandemic. nameOfConference

  
  

  DOI: 10.1097/01.ogx.0000822432.56370.10

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/75383
• Cibula D, Dostálek L, Jarkovsky J et al. (2022). Post-recurrence survival in patients with cervical cancer. nameOfConference

  
  

  DOI: 10.1016/j.ygyno.2021.12.018

  
  

  QMRO: qmroHref
• Gaba F, Goyal S, Marks D et al. (2022). Surgical decision making in premenopausal BRCA carriers considering risk-reducing early salpingectomy or salpingo-oophorectomy: A qualitative study. nameOfConference

  
  

  DOI: 10.1136/jmedgenet-2020-107501

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/69243
• Manchanda R (2022). Gynaecological Cancers Risk: Breast Cancer, Ovarian Cancer and Endometrial Cancer. nameOfConference

  
  

  DOI: 10.3390/books978-3-0365-2983-7

  
  

  QMRO: qmroHref
• Taylor JA, Burnell M, Ryan A et al. (2022). Association of hysterectomy and invasive epithelial ovarian and tubal cancer: a cohort study within UKCTOCS. nameOfConference

  
  

  DOI: 10.1111/1471-0528.16943

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/74278
• Kriplani D, Olivar AA, Tchrakian N et al. (2022). Concise Reporting of Benign Endometrial Biopsies is an Acceptable Alternative to Descriptive Reporting.. nameOfConference

  
  

  DOI: 10.1097/PGP.0000000000000761

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/67879
• Manchanda R, Gaba F, Talaulikar V et al. (2022). Risk-Reducing Salpingo-Oophorectomy and the Use of Hormone Replacement Therapy Below the Age of Natural Menopause: Scientific Impact Paper No. 66. nameOfConference

  
  

  DOI: 10.1111/1471-0528.16896

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/74884
• Manchanda R (2022). Special Issue “Gynaecological Cancers Risk: Breast Cancer, Ovarian Cancer and Endometrial Cancer”. nameOfConference

  
  

  DOI: 10.3390/cancers14020319

  
  

  QMRO: qmroHref
• Philpott S, Raikou M, Manchanda R et al. (2021). 423 Results of the avoiding late diagnosis of ovarian cancer (ALDO) project; a pilot national surveillance program for BRCA mutation-carriers. nameOfConference

  
  

  DOI: 10.1136/ijgc-2021-esgo.661

  
  

  QMRO: qmroHref
• Manchanda R, Oxley S, Ghaem-Maghami S et al. (2021). COVID-19 and the impact on gynecologic cancer care. nameOfConference

  
  

  DOI: 10.1002/ijgo.13868

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/73649
• Cibula D, Dostálek L, Jarkovsky J et al. (2021). The annual recurrence risk model for tailored surveillance strategy in patients with cervical cancer. nameOfConference

  
  

  DOI: 10.1016/j.ejca.2021.09.008

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/74692
• Sundar S, Cummins C, Balega J et al. (2021). 718 Investigating impact of ultra-radical surgery in advanced ovarian cancer using population level data linked to the SOCQER 2 multicentre study. Ovarian cancer

  
  

  DOI: 10.1136/ijgc-2021-esgo.452

  
  

  QMRO: qmroHref
• Reisel D, Burnell M, Side L et al. (2021). 874 Uptake of population based BRCA-testing across Jewish denominations and affect of cultural and religious factors: a cohort study. Prevention of gynaecologic cancer

  
  

  DOI: 10.1136/ijgc-2021-esgo.557

  
  

  QMRO: qmroHref
• Van Lonkhuijzen L, Dostalek L, Jarkovsky J et al. (2021). 942 Survival after recurrence in early-stage cervical cancer patients. Cervical cancer

  
  

  DOI: 10.1136/ijgc-2021-esgo.78

  
  

  QMRO: qmroHref
• Cibula D, Jarkovsky J, Van Lonkhuijzen L et al. (2021). 960 The annual recurrence risk model for tailored surveillance strategy in cervical cancer patients. Cervical cancer

  
  

  DOI: 10.1136/ijgc-2021-esgo.82

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/74887
• Gaba F, Blyuss O, Rodriguez I et al. (2021). 984 Impact of SARS-CoV-2 on training and mental wellbeing of surgical gynaecological oncology trainees. Miscellaneous

  
  

  DOI: 10.1136/ijgc-2021-esgo.284

  
  

  QMRO: qmroHref
• Rockall AG, Barwick TD, Wilson W et al. (publicationYear). DIAGNOSTIC ACCURACY OF FEC-PET/CT, FDG-PET/CT AND DIFFUSION-WEIGHTED MRI IN DETECTION OF NODAL METASTASES IN SURGICALLY TREATED ENDOMETRIAL AND CERVICAL CARCINOMA. nameOfConference

  
  

  DOI: 10.1158/1078-0432.ccr-21-1834

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/74146
• Gaba F, Blyuss O, Rodriguez I et al. (2021). Impact of SARS-CoV-2 on training and mental well-being of surgical gynecological oncology trainees.. nameOfConference

  
  

  DOI: 10.1136/ijgc-2021-002803

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/73179
• Chandrasekaran D, Sobocan M, Blyuss O et al. (2021). Implementation of multigene germline and parallel somatic genetic testing in epithelial ovarian cancer: Signpost study. nameOfConference

  
  

  DOI: 10.3390/cancers13174344

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/74102
• Menon U, Gentry-Maharaj A, Burnell M et al. (2021). Ovarian cancer population screening and mortality after long-term follow-up in the UK collaborative trial of ovarian cancer screening (UKCTOCS): A randomised controlled trial. nameOfConference

  
  

  DOI: 10.1097/01.ogx.0000792624.55995.3e

  
  

  QMRO: qmroHref
• Reisel D, Baran C, Manchanda R (publicationYear). Preventive population genomics- the model of BRCA related cancers. nameOfConference

  
  

  DOI: 10.1016/bs.adgen.2021.08.001

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/73806
• Oonk MH, Slomovitz B, Baldwin P et al. (2021). Radiotherapy versus inguinofemoral lymphadenectomy as treatment for vulvar cancer patients with micrometastases in the sentinel node: results of GROINSS-V II.. nameOfConference

  
  

  DOI: 10.1200/JCO.21.00006

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/73180
• Mariño IP, Vázquez MA, Blyuss O et al. (2021). Computational learning methods for early detection of ovarian cancer. Emerging Topics in Artificial Intelligence (ETAI) 2021

  
  

  DOI: 10.1117/12.2594225

  
  

  QMRO: qmroHref
• Menon U, Gentry-Maharaj A, Burnell M et al. (2021). Ovarian cancer population screening and mortality after long-term follow-up in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial. nameOfConference

  
  

  DOI: 10.1016/S0140-6736(21)00731-5

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/71892
• Phadnis S, Selek S, Farrag A et al. (2021). Cytoreduction surgery for recurrent ovarian cancer: cohort study from UK tertiary centre. nameOfConference

  
  

  DOI: doi

  
  

  QMRO: qmroHref
• Cohen PA, Powell A, Böhm S et al. (2021). Corrigendum to “Pathological chemotherapy response score is prognostic in tubo-ovarian high-grade serous carcinoma: A systematic review and meta-analysis of individual patient data” Gynecol. Oncol. 154 (2019) 441–448 (Gynecologic Oncology (2019) 154(2) (441–448), (S0090825819311813), (10.1016/j.ygyno.2019.04.679)). nameOfConference

  
  

  DOI: 10.1016/j.ygyno.2021.01.032

  
  

  QMRO: qmroHref
• Gaba F, Blyuss O, Chandrasekaran D et al. (2021). Attitudes towards risk-reducing early salpingectomy with delayed oophorectomy for ovarian cancer prevention: a cohort study. nameOfConference

  
  

  DOI: 10.1111/1471-0528.16424

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/66501
• Sundar S, Manchanda R, Gourley C et al. (2021). British Gynaecological Cancer Society/British Association of Gynaecological Pathology consensus for germline and tumor testing for BRCA1/2 variants in ovarian cancer in the United Kingdom.. nameOfConference

  
  

  DOI: 10.1136/ijgc-2020-002112

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/69786
• Gaba F, Robbani S, Singh N et al. (2021). Preventing Ovarian Cancer through early Excision of Tubes and late Ovarian Removal (PROTECTOR): Protocol for a prospective non-randomised multi-center trial. nameOfConference

  
  

  DOI: 10.1136/ijgc-2020-001541

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/67159
• Gaba F, Blyuss O, Sanderson S et al. (2020). 401 Population testing and personalised ovarian cancer risk prediction for risk adapted targeted prevention. Prevention of gynaecologic cancer

  
  

  DOI: 10.1136/ijgc-2020-esgo.159

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/69723
• Gaba F, Blyuss O, Legood R et al. (2020). 505 Attitudes towards risk reducing early salpingectomy with delayed oophorectomy for ovarian cancer prevention: a cohort study. Prevention of gynaecologic cancer

  
  

  DOI: 10.1136/ijgc-2020-esgo.160

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/69595
• Gaba F, Marks D, Saridogan E et al. (2020). 507 Surgical decision making in premenopausal brca carriers considering risk reducing early-salpingectomy or salpingo-oophorectomy: a qualitative study. Prevention of gynaecologic cancer

  
  

  DOI: 10.1136/ijgc-2020-esgo.161

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/69593
• Gallagher A, Waller J, Manchanda R et al. (2020). Women’s intentions to engage in risk-reducing behaviours after receiving personal ovarian cancer risk information: An experimental survey study. nameOfConference

  
  

  DOI: 10.3390/cancers12123543

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/68879
• Krämer P, Grube M, Renno T et al. (2020). 454 Study in progress: international retrospective study on lymphadenectomy in endometrioid ovarian carcinoma patients with early stage disease (LEOPARD). Poster

  
  

  DOI: 10.1136/ijgc-2020-igcs.394

  
  

  QMRO: qmroHref
• Krämer P, Talhouk A, Brett MA et al. (2020). Endometrial cancer molecular risk stratification is equally prognostic for endometrioid ovarian carcinoma. nameOfConference

  
  

  DOI: 10.1158/1078-0432.CCR-20-1268

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/66346
• Grube M, Krämer P, Chiu D et al. (2020). Immunhistochemische Expression von L1CAM in endometrioiden Ovarialkarzinomen – Ein neuer prognostischer Marker?. Kongressabstracts zur Tagung 2020 der Deutschen Gesellschaft für Gynäkologie und Geburtshilfe (DGGG)

  
  

  DOI: 10.1055/s-0040-1718139

  
  

  QMRO: qmroHref
• Manchanda R, Lieberman S, Gaba F et al. (2020). Population Screening for Inherited Predisposition to Breast and Ovarian Cancer. nameOfConference

  
  

  DOI: 10.1146/annurev-genom-083118-015253

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/68523
• Evans O, Manchanda R (2020). Population-based genetic testing for precision prevention. nameOfConference

  
  

  DOI: 10.1158/1940-6207.CAPR-20-0002

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/65425
• Manchanda R, Sun L, Patel S et al. (2020). Economic evaluation of population-based brca1/brca2 mutation testing across multiple countries and health systems. nameOfConference

  
  

  DOI: 10.3390/cancers12071929

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/68194
• Gentry-Maharaj A, Blyuss O, Ryan A et al. (2020). Multi-marker longitudinal algorithms incorporating HE4 and CA125 in ovarian cancer screening of postmenopausal women. nameOfConference

  
  

  DOI: 10.3390/cancers12071931

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/68195
• Gaba F, Blyuss O, Liu X et al. (2020). Population study of ovarian cancer risk prediction for targeted screening and prevention. nameOfConference

  
  

  DOI: 10.3390/cancers12051241

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/64757
• Cohen PA, Powell A, Böhm S et al. (2020). Corrigendum to “Pathological chemotherapy response score is prognostic in tubo-ovarian high-grade serous carcinoma: A systematic review and meta-analysis of individual patient data” [Gynecol. Oncol. 154 (2019) 441–448] (Gynecologic Oncology (2019) 154(2) (441–448), (S0090825819311813), (10.1016/j.ygyno.2019.04.679)). nameOfConference

  
  

  DOI: 10.1016/j.ygyno.2020.02.023

  
  

  QMRO: qmroHref
• Manchanda R, Buist DSM, Evans DGR (2020). Future Research Suggestions for Multigene Testing in Unselected Populations-Reply. nameOfConference

  
  

  DOI: 10.1001/jamaoncol.2020.0131

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/65657
• Evans O, Gaba F, Manchanda R (2020). Population-based genetic testing for Women's cancer prevention. nameOfConference

  
  

  DOI: 10.1016/j.bpobgyn.2020.02.007

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/64715
• Manchanda R (2020). Advances in the screening and prevention of Women's cancers. nameOfConference

  
  

  DOI: 10.1016/j.bpobgyn.2020.03.008

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/64691
• Casey L, Powell A, Bohm S et al. (2020). Role of Ki67 Proliferation Index and CD8 Tumour-Infitrating Lymphocyte Counts in Predicting Outcome in High-Grade Serous Tubo-Ovarian Carcinoma (HGSC) Showing No/Partial Response to Neoadjuvant Chemotherapy. nameOfConference

  
  

  DOI: doi

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/68674
• Gaba F, Manchanda R (2020). Systematic review of acceptability, cardiovascular, neurological, bone health and HRT outcomes following risk reducing surgery in BRCA carriers. nameOfConference

  
  

  DOI: 10.1016/j.bpobgyn.2020.01.006

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/66571
• Manchanda R, Burnell M, Gaba F et al. (2020). Randomised trial of population-based BRCA testing in Ashkenazi Jews: long-term outcomes. nameOfConference

  
  

  DOI: 10.1111/1471-0528.15905

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/60978
• Ryan N, Wall J, Crosbie EJ et al. (2019). Lynch syndrome screening in gynaecological cancers: results of an international survey with recommendations for uniform reporting terminology for mismatch repair immunohistochemistry results. nameOfConference

  
  

  DOI: 10.1111/his.13925

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/60981
• Gaba F, Chandrasekaran D, Menon U et al. (2019). EP1229 Preventing ovarian cancer through early excision of tubes and late ovarian removal (PROTECTOR) study. ePoster Talks: Ovarian + Endometria

  
  

  DOI: 10.1136/ijgc-2019-esgo.63

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/66640
• Gaba F, Liu X, Chandrasekaran D et al. (2019). EP1231 Impact of population genetic testing and ovarian cancer risk stratification on the emotional well-being and health of unselected women in a general population. ePoster Talks: Ovarian + Endometria

  
  

  DOI: 10.1136/ijgc-2019-esgo.65

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/65700
• Sundar S, Cummins C, Kumar S et al. (2019). EP1269 Quality of life after surgery of varying surgical complexity in advanced ovarian cancer: results from the international, prospective, multicenter cohort SOCQER2 study. ePoster

  
  

  DOI: 10.1136/ijgc-2019-esgo.1275

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/66598
• Daia M, Chandrasekaran D, Lawrence A et al. (2019). EP1332 Follow the yellow brick road – Supra-renal para-aortic lymphadenectomy for metastatic ovarian cancer. Cinema Viewing

  
  

  DOI: 10.1136/ijgc-2019-esgo.1336

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/65649
• Gaba F, Farrag A, Lawrence A et al. (2019). EP1342 Ovarian cancer with metastatic inguinal lymphadenopathy: an abdominal approach to inguinal nodes dissection. Cinema Viewing

  
  

  DOI: 10.1136/ijgc-2019-esgo.1346

  
  

  QMRO: qmroHref
• Dokmeci A, Abdurrayman M, Drymiotou S et al. (2019). EP507 Has the robot been beneficial to endometrial cancer patients? A prospective quality improvement project at a london gynae-oncology tertiary centre. ePoster

  
  

  DOI: 10.1136/ijgc-2019-esgo.565

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/65682
• Drymiotou S, Dokmeci A, Chandrasekaran D et al. (2019). EP510 Robotic surgery: does high body mass index (BMI) matter?. ePoster

  
  

  DOI: 10.1136/ijgc-2019-esgo.568

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/67592
• Manchanda R, Burnell M, Gaba F et al. (2019). Randomised trial of unselected BRCA testing in ashkenazi jews: long term outcomes and factors affecting uptake of testing. Best Oral/Late-Breaking Abstracts 4 – Miscellaneous

  
  

  DOI: 10.1136/ijgc-2019-esgo.15

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/66610
• Sun L, Brentnall A, Patel S et al. (2019). Should we offer multi-gene testing to all patients with breast cancer: a cost-effectiveness analysis. Oral Communication 4 – Gynaecological Cancer

  
  

  DOI: 10.1136/ijgc-2019-esgo.31

  
  

  QMRO: qmroHref
• Sun L, Brentnall A, Patel S et al. (publicationYear). A Cost-effectiveness Analysis of Multigene Testing for All Patients with Breast Cancer. nameOfConference

  
  

  DOI: 10.1001/jamaoncol.2019.3323

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/64584
• Manchanda R, Sun L, Patel S et al. (2019). 10 Global economic evaluation of population-based BRCA1/BRCA2 mutation testing. Plenary sessions

  
  

  DOI: 10.1136/ijgc-2019-igcs.10

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/63059
• Sun L, Brentnall A, Patel S et al. (2019). 66 Should we offer multi-gene testing to all patients with breast cancer: a cost-effectiveness analysis. nameOfConference

  
  

  DOI: 10.1136/ijgc-2019-igcs.66

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/65196
• Manchanda R, Burnell M, Gaba F et al. (2019). 81 Attitude towards and factors affecting uptake of population based BRCA testing in ashkenazi jews: a cohort study. E-Poster discussions

  
  

  DOI: 10.1136/ijgc-2019-igcs.81

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/62727
• Tan A, Rivas C, Yorke S et al. (2019). Variation in the outcome reported by studies of interventions for atypical endometrial hyperplasia: a systematic review (the first step in the development of CRUK-funded Core Outcome Sets). RCOG World Congress 2019

  
  

  DOI: 10.1111/1471-0528.6_15703

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/62201
• Tan A, Rivas C, Yorke S et al. (2019). Key patient outcomes on studies managing atypical endometrial hyperplasia and endometrial cancer: two sets of patient workshops and semi-structured interviews (the second step in the development of CRUK-funded Core Outcome Sets). nameOfConference

  
  

  DOI: doi

  
  

  QMRO: qmroHref
• Tan A, Rivas C, Yorke S et al. (2019). Variation in the outcome reported by studies of fertility-sparing interventions for atypical endometrial hyperplasia and early endometrial cancer: a systematic review (the first step in the development of CRUK-funded Core Outcome Sets). nameOfConference

  
  

  DOI: doi

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/62203
• Tan A, Rivas C, Yorke S et al. (2019). Variation in the outcome reported by studies of interventions for endometrial cancer: a systematic review (the first step in the development of CRUK-funded Core Outcome Sets). nameOfConference

  
  

  DOI: doi

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/62202
• Cohen PA, Powell A, Böhm S et al. (2019). Pathological chemotherapy response score is prognostic in tubo-ovarian high-grade serous carcinoma: A systematic review and meta-analysis of individual patient data. nameOfConference

  
  

  DOI: 10.1016/j.ygyno.2019.04.679

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/58607
• Cohen P, Powell A, Böhm S et al. (2019). Pathological Chemotherapy Response Score Predicts Survival in Patients with Advanced Ovarian Cancer Receiving Neoadjuvant Chemotherapy: Systematic Review and Meta-Analysis of Individual Patient Data. nameOfConference

  
  

  DOI: 10.1016/j.ygyno.2019.04.679

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/65809
• Crosbie E, MANCHANDA R, Manchester International Consensus Group (2019). The Manchester International Consensus Group recommendations for the management of gynecological cancers in Lynch syndrome. nameOfConference

  
  

  DOI: 10.1038/s41436-019-0489-y

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/56622
• GABA F, Piek J, Menon U et al. (2019). Risk reducing early salpingectomy and delayed oophorectomy as a two staged alternative for primary prevention of ovarian cancer in increased risk women: a commentary. nameOfConference

  
  

  DOI: 10.1111/1471-0528.15651

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/55319
• MANCHANDA R, GABA F (2019). A commentary on population genetic testing for primary prevention: changing landscape and the need to change paradigm. nameOfConference

  
  

  DOI: 10.1111/1471-0528.15657

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/55616
• Koutoukidis D, Beeken R, MANCHANDA R et al. (2019). Diet, physical activity, and health-related outcomes of endometrial cancer survivors in a behavioural lifestyle programme: the Diet and Exercise in Uterine Cancer Survivors (DEUS) parallel randomised controlled pilot trial. nameOfConference

  
  

  DOI: 10.1136/ijgc-2018-000039

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/49823
• MANCHANDA R, Matthew B, GABA F et al. (2019). Attitude towards and factors affecting uptake of population based BRCA testing in the Ashkenazi Jewish population: a cohort study. nameOfConference

  
  

  DOI: 10.1111/1471-0528.15654

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/55771
• Osman M, Chandrasekaran D, Musa E et al. (2018). Evaluation of the diagnostic hysteroscopy service in gynaecology oncology. National Trainees Conference 2018

  
  

  DOI: doi

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/56070
• MANCHANDA R, GABA F (2018). Population Based Testing for Primary Prevention: A Systematic Review. nameOfConference

  
  

  DOI: 10.3390/cancers10110424

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/51824
• Puntambekar S, MANCHANDA R (2018). Surgical pelvic anatomy in gynecologic oncology.. nameOfConference

  
  

  DOI: 10.1002/ijgo.12616

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/47924
• Manchanda R, Gaba F (2018). Population Based Testing for Primary Prevention: A Systematic Review. nameOfConference

  
  

  DOI: 10.20944/preprints201809.0602.v1

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/52323
• MANCHANDA R, Legood R (publicationYear). Population based germline testing for primary cancer prevention. nameOfConference

  
  

  DOI: 10.18632/oncotarget.25995

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/45084
• Jiang J, Phadnis S, Miller R et al. (2018). DISTANT RECURRENCES ARE COMMON FOLLOWING PELVIC EXENTERATION FOR MALIGNANCY OF NON-CERVICAL ORIGIN. nameOfConference

  
  

  DOI: doi

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/65572
• Jiang J, Phadnis S, Miller R et al. (2018). OUTCOMES OF BOWEL RESECTIONS DURING SURGICAL CYTOREDUCTION OF ADVANCED STAGE OVARIAN CANCER: SHOULD WE BE WORKING TOWARDS REDUCING STOMA RATES?. nameOfConference

  
  

  DOI: doi

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/65786
• Singh N, Piskorz A, Bosse T et al. (2018). P53 IMMUNOHISTOCHEMISTRY AS A SURROGATE FOR TP53 MUTATIONAL ANALYSIS IN ENDOMETRIAL CANCER BIOPSIES. nameOfConference

  
  

  DOI: doi

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/69398
• Sundar S, Kumar S, Long J et al. (2018). PATIENT REPORTED OUTCOMES (PRO) AFTER SURGERY IN ADVANCED OVARIAN CANCER - INITIAL RESULTS FROM THE INTERNATIONAL, PROSPECTIVE, MULTICENTER SOCQER 2 STUDY. nameOfConference

  
  

  DOI: doi

  
  

  QMRO: qmroHref
• Farrag A, Light M, Sahdev A et al. (2018). SOLITARY RECURRENCE OF SQUAMOUS CELL CARCINOMA OF THE CERVIX IN THE OMENTUM - MANAGEMENT OF AN UNUSUAL PRESENTATION. nameOfConference

  
  

  DOI: doi

  
  

  QMRO: qmroHref
• Manchanda R, Blyuss O, Gaba F et al. (2018). Current detection rates and time-to-detection of all identifiable BRCA carriers in the Greater London population. nameOfConference

  
  

  DOI: 10.1136/jmedgenet-2017-105195

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/38363
• Yang X, Leslie G, Gentry-Maharaj A et al. (2018). Evaluation of polygenic risk scores for ovarian cancer risk prediction in a prospective cohort study. nameOfConference

  
  

  DOI: 10.1136/jmedgenet-2018-105313

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/37923
• Vazquez MA, Marino IP, BLYUSS O et al. (2018). A quantitative performance study of two automatic methods for the diagnosis of ovarian cancer. nameOfConference

  
  

  DOI: 10.1016/j.bspc.2018.07.001

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/42483
• BLYUSS O, Burnell M, Ryan A et al. (2018). Comparison of longitudinal CA125 algorithms as a first line screen for ovarian cancer in the general population. nameOfConference

  
  

  DOI: 10.1158/1078-0432.CCR-18-0208

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/42484
• Manchanda R, Patel S, Gordeev VS et al. (2018). Cost-effectiveness of population-based BRCA1, BRCA2, RAD51C, RAD51D, BRIP1, PALB2 mutation testing in unselected general population women. nameOfConference

  
  

  DOI: 10.1093/jnci/djx265

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/35943
• Chuang L, Berek J, Randall T et al. (2018). Collaborations in gynecologic oncology education and research in low- and middle- income countries: Current status, barriers and opportunities. nameOfConference

  
  

  DOI: 10.1016/j.gore.2018.05.005

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/41283
• Mariño IP, Vázquez MA, Blyuss O et al. (2018). Diagnosis of ovarian cancer based on longitudinal measurements of multiple biomarkers. nameOfConference

  
  

  DOI: doi

  
  

  QMRO: qmroHref
• Crusz SM, Chandrasekaran D, Phadnis S et al. (2018). Outcome of patients undergoing delayed debulking surgery (DDS) in advanced ovarian cancer (OC).. nameOfConference

  
  

  DOI: 10.1200/jco.2018.36.15_suppl.e17530

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/65785
• Chandrasekaran D, Manchanda R (2018). Germline & somatic genetic testing in ovarian cancer patients.. nameOfConference

  
  

  DOI: 10.1111/1471-0528.15225

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/36592
• Patel S, Legood R, Evans DG et al. (2018). Cost effectiveness of population based BRCA1 founder mutation testing in Sephardi Jewish women. nameOfConference

  
  

  DOI: 10.1016/j.ajog.2017.12.221

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/31164
• Chandrasekaran D, Gaba F, Manchanda R (2018). Preinvasive Disease, Screening and Hereditary Cancer. nameOfConference

  
  

  DOI: 10.1017/9781316986844.008

  
  

  QMRO: qmroHref
• MANCHANDA R, Menon U (2018). Setting the threshold for surgical prevention in women at increased risk of ovarian cancer. nameOfConference

  
  

  DOI: 10.1097/IGC.0000000000001147

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/31163
• Meisel SF, Freeman M, Waller J et al. (2017). Impact of a decision aid about stratified ovarian cancer risk-management on women’s knowledge and intentions: a randomised online experimental survey study. nameOfConference

  
  

  DOI: 10.1186/s12889-017-4889-0

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/29163
• Manchanda R, Patel S, Antoniou AC et al. (2017). Cost-effectiveness of population based BRCA testing with varying Ashkenazi Jewish ancestry. nameOfConference

  
  

  DOI: 10.1016/j.ajog.2017.06.038

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/24965
• Manchanda R, Gaba F, Bottla K et al. (2017). PREDICTING RISK OF OVARIAN MALIGNANCY IMPROVED SCREENING AND EARLY DETECTION FEASIBILITY STUDY (PROMISE-FS). nameOfConference

  
  

  DOI: doi

  
  

  QMRO: qmroHref
• Koutoukidis DA, Beeken RJ, Manchanda R et al. (2017). Recruitment, adherence, and retention of endometrial cancer survivors in a behavioural lifestyle programme: The Diet and Exercise in Uterine Cancer Survivors (DEUS) parallel randomised pilot trial. nameOfConference

  
  

  DOI: 10.1136/bmjopen-2017-018015

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/30603
• Gan C, Chenoy R, Chandrasekaran D et al. (2017). Persistence of fimbrial tissue on the ovarian surface after salpingectomy. nameOfConference

  
  

  DOI: 10.1016/j.ajog.2017.06.004

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/24890
• Rosenthal AN, Fraser LSM, Philpott S et al. (2017). Evidence of Stage Shift in Women Diagnosed with Ovarian Cancer during Phase II of the United Kingdom Familial Ovarian Cancer Screening Study. nameOfConference

  
  

  DOI: 10.1097/01.ogx.0000520207.28837.3a

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/48284
• Bansal JK, Goldrick IG, Manchanda R et al. (2017). Rapid-access gynecological oncology clinic outcomes in North London, UK. nameOfConference

  
  

  DOI: 10.2147/ca.s127369

  
  

  QMRO: qmroHref
• MANCHANDA R, Legood R, Antoniou AC et al. (2017). Changing the Risk Threshold for Surgical Prevention of Ovarian Cancer. nameOfConference

  
  

  DOI: 10.1111/1471-0528.14763

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/24546
• Rosenthal AN, Fraser LSM, Philpott S et al. (2017). Evidence of Stage Shift in Women Diagnosed With Ovarian Cancer During Phase II of the United Kingdom Familial Ovarian Cancer Screening Study.. nameOfConference

  
  

  DOI: 10.1200/JCO.2016.69.9330

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/21300
• Johnston C, Ng JS, Manchanda R et al. (2017). Variations in gynecologic oncology training in low (LIC) and middle income (MIC) countries (LMICs): Common efforts and challenges. nameOfConference

  
  

  DOI: 10.1016/j.gore.2017.01.003

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/19546
• Manchanda R (2017). Opportunistic salpingectomy for prevention of ovarian cancer. nameOfConference

  
  

  DOI: 10.1111/1471-0528.14655

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/23063
• Gan C, Bossart M, Piek J et al. (2017). Robotic and Advanced Laparoscopic Surgical Training in European Gynecological Oncology Trainees.. nameOfConference

  
  

  DOI: 10.1097/IGC.0000000000000879

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/19547
• Koutoukidis DA, Beeken RJ, Manchanda R et al. (2017). Erratum: Diet and exercise in uterine cancer survivors (DEUS pilot) - piloting a healthy eating and physical activity program: Study protocol for a randomized controlled trial. [Trials. (2016), 17, (130)], DOI: 10.1186/s13063-016-1260-1. nameOfConference

  
  

  DOI: 10.1186/s13063-017-1776-z

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/19539
• Gaba FM, Manchanda R, Gaba FM et al. (2017). Genetic testing for gynaecological cancer. nameOfConference

  
  

  DOI: 10.1016/j.ogrm.2016.11.001

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/18971
• Burnell M, Iyer R, Gentry-Maharaj A et al. (2016). Benchmarking of surgical complications in gynaecological oncology: Prospective multicentre study. nameOfConference

  
  

  DOI: 10.1111/1471-0528.13994

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/12657
• Pennington M, Gentry-Maharaj A, Karpinskyj C et al. (2016). Long-Term Secondary Care Costs of Endometrial Cancer: A Prospective Cohort Study Nested within the United Kingdom Collaborative Trial of Ovarian Cancer Screening (UKCTOCS).. nameOfConference

  
  

  DOI: 10.1371/journal.pone.0165539

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/17827
• La Russa M, Biliatis I, Brockbank E et al. (2016). CONSERVATIVE TREATMENT FOR FERTILITY SPARING IN YOUNG WOMEN WITH ENDOMETRIAL CANCER AND ATYPICAL HYPERPLASIA. RESULTS FROM A ON GOING PROSPECTIVE SINGLE CENTRE STUDY. 16th biennial International Gynecologic Cancer Society (IGCS) meeting

  
  

  DOI: doi

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/18943
• Manchanda R, Gordeev V, Antoniou A et al. (2016). Cost-effectiveness of systematic population based screening for BRCA1, BRCA2, RAD51C, RAD51D and BRIP1 gene mutations in unselected general population women. 16th Biennial Meeting of the International Gynecologic Cancer Society (IGCS 2016)

  
  

  DOI: doi

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/18946
• Phadnis S, Vali S, Oram D et al. (2016). Enhanced recovery after major gynaecological oncology surgery: Are we meeting the standards?. nameOfConference

  
  

  DOI: doi

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/65625
• Phadnis S, Lawrence A, Oram D et al. (2016). Morbidity and mortality following major surgery for gynaecological malignancy: A prospective observational study from a cancer centre in London. nameOfConference

  
  

  DOI: doi

  
  

  QMRO: qmroHref
• Kumar S, Long J, Rudge G et al. (2016). SOCQER-2 Study: Preliminary analysis of multicentre recruitment after surgery in advanced ovarian cancer. 16th biennial International Gynecologic Cancer Society (IGCS) meeting, Lisbon, Portugal

  
  

  DOI: doi

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/24955
• Phadnis S, Korompelis P, Iamprou C et al. (2016). Surgical and oncological outcome of morbidly obese (BMI > 40) women having laparoscopic surgery for early stage endometrial cancer. nameOfConference

  
  

  DOI: doi

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/65947
• Manchanda R, Legood R, Antoniou AC et al. (2016). Specifying the ovarian cancer risk threshold of 'premenopausal risk-reducing salpingooophorectomy' for ovarian cancer prevention: A cost-effectiveness analysis. nameOfConference

  
  

  DOI: 10.1136/jmedgenet-2016-103800

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/13144
• Manchanda R, Burnell M, Loggenberg K et al. (2016). Cluster-randomised non-inferiority trial comparing DVD-assisted and traditional genetic counselling in systematic population testing for BRCA1/2 mutations. nameOfConference

  
  

  DOI: 10.1136/jmedgenet-2015-103740

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/12152
• Chuang LT, Randall TC, Denny L et al. (2016). Sister Society Meeting on Global Education Development and Collaboration: Meeting Report. nameOfConference

  
  

  DOI: 10.1097/IGC.0000000000000735

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/15553
• Manchanda R, Cibula D (2016). Ovarian Cancer Screening There May Be Light at the End of the Tunnel?. nameOfConference

  
  

  DOI: 10.1097/IGC.0000000000000706

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/12881
• Koutoukidis DA, Beeken RJ, Manchanda R et al. (2016). Diet and exercise in uterine cancer survivors (DEUS pilot) - piloting a healthy eating and physical activity program: Study protocol for a randomized controlled trial. nameOfConference

  
  

  DOI: 10.1186/s13063-016-1260-1

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/12157
• MANCHANDA R, Menon U (2016). Opportunistic bilateral salpingectomy (OBS) for the prevention of ovarian cancer should be offered in the context of a clinical trial FOR: There is lack of clarity on a number of key issues. nameOfConference

  
  

  DOI: 10.1111/1471-0528.13741

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/11153
• Manchanda R, Jacobs I (2016). Genetic screening for gynecological cancer: Where are we heading?. nameOfConference

  
  

  DOI: 10.2217/fon.15.278

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/10784
• Manchanda R, Chandrasekaran D, Saridogan E et al. (2016). Should Opportunistic Bilateral Salpingectomy (OBS) for Prevention of Ovarian Cancer Be Incorporated into Routine Care or Offered in the Context of a Clinical Trial?. nameOfConference

  
  

  DOI: 10.1097/IGC.0000000000000567

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/10777
• Blyuss KB, MANCHANDA R, Kurths J et al. (2016). Systems Medicine of Cancer: Bringing Together Clinical Data and Nonlinear Dynamics of Genetic Networks. nameOfConference

  
  

  DOI: 10.1155/2016/7904693

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/11154
• Dilley J, Manchanda R, Johnson M et al. (2016). Importance of serial CA125 measurements over an absolute cut-off value for the detection of asymptomatic ovarian cancer in high-risk patients. nameOfConference

  
  

  DOI: 10.1016/j.ijgo.2015.09.013

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/12243
• Manchanda R, Legood R, Pearce L et al. (2015). Defining the risk threshold for risk reducing salpingo-oophorectomy for ovarian cancer prevention in low risk postmenopausal women. nameOfConference

  
  

  DOI: 10.1016/j.ygyno.2015.10.001

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/10775
• Manchanda R, Loggenberg K, Burnell M et al. (2015). A NON-INFERIORITY CLUSTER RANDOMISED TRIAL COMPARING TRADITIONAL FACE-TO-FACE AND DVD-BASED GENETIC COUNSELLING IN SYSTEMATIC POPULATION BASED BRCA1/2 TESTING. nameOfConference

  
  

  DOI: doi

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/39589
• Chandrasekaran D, Menon U, Evans G et al. (2015). Risk Reducing Salpingectomy and Delayed Oophorectomy in high risk women: views of cancer geneticists, genetic counsellors and gynaecological oncologists in the UK. nameOfConference

  
  

  DOI: 10.1007/s10689-015-9823-y

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/10800
• Chandrasekaran D, Menon U, Evans G et al. (2015). Risk reducing salpingectomy and delayed oophorectomy in high risk women: views of cancer geneticists, genetic counsellors and gynaecological oncologists in the UK. nameOfConference

  
  

  DOI: 10.1007/s10689-015-9823-y

  
  

  QMRO: qmroHref
• Iyer R, Gentry-Maharaj A, Nordin A et al. (2015). Predictors of complications in gynaecological oncological surgery: A prospective multicentre study (UKGOSOC - UK gynaecological oncology surgical outcomes and complications). nameOfConference

  
  

  DOI: 10.1038/bjc.2014.630

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/12471
• Jervis S, Song H, Lee A et al. (2015). A risk prediction algorithm for ovarian cancer incorporating BRCA1, BRCA2, common alleles and other familial effects. nameOfConference

  
  

  DOI: 10.1136/jmedgenet-2015-103077

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/12239
• Manchanda R, Legood R, Burnell M et al. (2015). Cost-effectiveness of population screening for BRCA mutations in Ashkenazi Jewish women compared with family history-based testing. nameOfConference

  
  

  DOI: 10.1093/jnci/dju380

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/11002
• Manchanda R, Loggenberg K, Sanderson S et al. (2015). Population testing for cancer predisposing BRCA1/BRCA2 mutations in the ashkenazi-jewish community: A randomized controlled trial. nameOfConference

  
  

  DOI: 10.1093/jnci/dju379

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/12434
• Piek J, Bossart M, Boor K et al. (2015). The work place educational climate in gynecological oncology fellowships across Europe the impact of accreditation. nameOfConference

  
  

  DOI: 10.1097/IGC.0000000000000323

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/14953
• Manchanda R, Sanderson S, Loggenberg K et al. (2014). POPULATION PREVALENCE OF UK ASHKENAZI BRCA-MUTATIONS, PERFORMANCE OF AND ESTIMATED TIME-TO, FAMILY-HISTORY BASED IDENTIFICATION OF ALL BRCA CARRIERS.. nameOfConference

  
  

  DOI: doi

  
  

  QMRO: qmroHref
• Manchanda R, Legood R, Burnell M et al. (2014). POPULATION-BASED TESTING FOR BRCA MUTATIONS (COMPARED TO FAMILY-HISTORY BASED TESTING) MAY BE COST SAVING IN ASHKENAZI-JEWS: A HEALTH-ECONOMICS DECISION ANALYTICAL MODEL. nameOfConference

  
  

  DOI: doi

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/12313
• Manchanda R, Gessler S, Loggenberg K et al. (2014). Population Testing for Inherited, Cancer Predisposing BRCA 1 and BRCA2 Founder Mutations in the Ashkenazi Jewish Community in London: The Psychological Impact on Participants of a Randomised Controlled Trial. nameOfConference

  
  

  DOI: doi

  
  

  QMRO: qmroHref
• Philpott S, Rizzuto I, Fraser L et al. (2013). DETECTION OF NON-OVARIAN CANCERS ON PHASE 2 OF THE UK FAMILIAL OVARIAN CANCER SCREENING STUDY (UKFOCSS). nameOfConference

  
  

  DOI: doi

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/45783
• Manchanda R, Legood R, Burnell M et al. (2013). POPULATION BASED TESTING FOR BRCA MUTATIONS IS HIGHLY COST-EFFECTIVE COMPARED TO FAMILY HISTORY BASED APPROACH: A HEALTH-ECONOMIC DECISION ANALYTICAL MODEL FROM THE GCAPPS TRIAL. nameOfConference

  
  

  DOI: doi

  
  

  QMRO: qmroHref
• Rosenthal AN, Fraser L, Philpott S et al. (2013). RESULTS OF INTENSIVE ALGORITHM-BASED SCREENING IN THE UK FAMILIAL OVARIAN CANCER SCREENING STUDY (UK FOCSS PHASE 2). nameOfConference

  
  

  DOI: doi

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/56557
• Manchanda R, Halaska MJ, Piek JM et al. (2013). The need for more workshops in laparoscopic surgery and surgical anatomy for european gynaecological oncology trainees: A survey by the european network of young gynaecological oncologists. nameOfConference

  
  

  DOI: 10.1097/IGC.0b013e31829703b0

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/12334
• Rosenthal AN, Fraser L, Philpott S et al. (2013). Final results of 4-monthly screening in the UK Familial Ovarian Cancer Screening Study (UKFOCSS Phase 2). nameOfConference

  
  

  DOI: doi

  
  

  QMRO: qmroHref
• Rosenthal AN, Fraser L, Philpott S et al. (2013). Final results of 4-monthly screening in the UK Familial Ovarian Cancer Screening Study (UKFOCSS Phase 2).. nameOfConference

  
  

  DOI: 10.1200/jco.2013.31.15_suppl.5507

  
  

  QMRO: qmroHref
• Kalsi JK, Manchanda R, Menon U (2013). Screening for gynecological cancers. nameOfConference

  
  

  DOI: 10.1586/eog.13.5

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/13602
• Rosenthal AN, Fraser L, Manchanda R et al. (2013). Results of annual screening in phase I of the United Kingdom familial ovarian cancer screening study highlight the need for strict adherence to screening schedule. nameOfConference

  
  

  DOI: 10.1200/JCO.2011.39.7638

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/13391
• Manchanda R, Godfrey M, Wong-Taylor LA et al. (2013). The need for accredited training in gynaecological oncology: A report from the european network of young gynaecological oncologists (ENYGO). nameOfConference

  
  

  DOI: 10.1093/annonc/mds588

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/12226
• Manchanda R, Drapkin R, Menon U (2013). There is a need for routine peritoneal cytology at RRSO. nameOfConference

  
  

  DOI: 10.1016/j.ygyno.2012.09.031

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/12304
• Manchanda R, Saridogan E, Abdelraheim A et al. (2012). Annual outpatient hysteroscopy and endometrial sampling (OHES) in HNPCC/Lynch syndrome (LS). nameOfConference

  
  

  DOI: 10.1007/s00404-012-2492-2

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/12296
• Fourkala EO, Gentry-Maharaj A, Burnell M et al. (2012). Histological confirmation of breast cancer registration and self-reporting in England and Wales: A cohort study within the UK Collaborative Trial of Ovarian Cancer Screening. nameOfConference

  
  

  DOI: 10.1038/bjc.2012.155

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/10809
• Manchanda R, Silvanto A, Abdelraheim A et al. (2012). Diathermy-induced injury may affect detection of occult tubal lesions at risk-reducing salpingo-oophorectomy. nameOfConference

  
  

  DOI: 10.1097/IGC.0b013e31824b4093

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/12233
• Menon U, Kalsi J, Jacobs I et al. (2012). International conference on ovarian cancer screening 29th-30th November 2011, Royal College of Physicians, London. nameOfConference

  
  

  DOI: 10.1097/IGC.0b013e3182557e41

  
  

  QMRO: qmroHref
• Manchanda R, Burnell M, Abdelraheim A et al. (2012). Factors influencing uptake and timing of risk reducing salpingo- oophorectomy in women at risk of familial ovarian cancer: A competing risk time to event analysis. nameOfConference

  
  

  DOI: 10.1111/j.1471-0528.2011.03257.x

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/12664
• Gentry-Maharaj A, Kalsi J, Burnell M et al. (2012). Screening of symptomatic women for ovarian cancer. nameOfConference

  
  

  DOI: 10.1016/S1470-2045(12)70120-1

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/13651
• Vaes E, Manchanda R, Autier P et al. (2012). Differential diagnosis of adnexal masses: Sequential use of the risk of malignancy index and HistoScanning, a novel computer-aided diagnostic tool. nameOfConference

  
  

  DOI: 10.1002/uog.9079

  
  

  QMRO: qmroHref
• Brantnerova R, Manchanda R, Colombo N (2012). The European society of gynaecological oncology: update on objectives and educational and research activities.. nameOfConference

  
  

  DOI: 10.14694/EdBook_AM.2012.32.55

  
  

  QMRO: qmroHref
• Manchanda R, Drapkin R, Jacobs I et al. (2012). The role of peritoneal cytology at risk-reducing salpingo-oophorectomy (RRSO) in women at increased risk of familial ovarian/tubal cancer. nameOfConference

  
  

  DOI: 10.1016/j.ygyno.2011.10.017

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/12268
• Gultekin M, Dursun P, Vranes B et al. (2011). Gynecologic oncology training systems in Europe: A report from the European network of young gynaecological oncologists. nameOfConference

  
  

  DOI: 10.1097/IGC.0b013e3182202d17

  
  

  QMRO: qmroHref
• Manchanda R, Abdelraheim A, Johnson M et al. (2011). Outcome of risk-reducing salpingo-oophorectomy in BRCA carriers and women of unknown mutation status. nameOfConference

  
  

  DOI: 10.1111/j.1471-0528.2011.02920.x

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/14031
• (2011). Cross-sectional imaging. nameOfConference

  
  

  DOI: 10.3109/9781841847658-8

  
  

  QMRO: qmroHref
• Vaes E, Manchanda R, Nir R et al. (2011). Mathematical models to discriminate between benign and malignant adnexal masses: Potential diagnostic improvement using ovarian histoscanning. nameOfConference

  
  

  DOI: 10.1097/IGC.0b013e3182000528

  
  

  QMRO: qmroHref
• Jacobs I, Gentry-Maharaj A, Burnell M et al. (2011). Sensitivity of transvaginal ultrasound screening for endometrial cancer in postmenopausal women: A case-control study within the UKCTOCS cohort. nameOfConference

  
  

  DOI: 10.1016/S1470-2045(10)70268-0

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/15120
• Pichert G, Jacobs C, Jacobs I et al. (2010). Novel one-stop multidisciplinary follow-up clinic significantly improves cancer risk management in BRCA1/2 carriers. nameOfConference

  
  

  DOI: 10.1007/s10689-010-9333-x

  
  

  QMRO: qmroHref
• Vaes E, Manchanda R, Nir R et al. (2009). 1329 A sequential use of the Risk of Malignancy Index and Ovarian HistoScanning for the differential diagnosis of adnexal masses. nameOfConference

  
  

  DOI: 10.1016/s1359-6349(09)70502-6

  
  

  QMRO: qmroHref
• Manchanda R, Rosenthal A, Burnell M et al. (2009). Change in stage distribution observed with annual screening for ovarian cancer in BRCA carriers. nameOfConference

  
  

  DOI: 10.1136/jmg.2009.067462

  
  

  QMRO: qmroHref
• Manchanda R, Menon U, Michaelson-Cohen R et al. (2009). Hereditary non-polyposis colorectal cancer or Lynch syndrome: The gynaecological perspective. nameOfConference

  
  

  DOI: 10.1097/GCO.0b013e32831c844d

  
  

  QMRO: qmroHref
• Manchanda R, Baldwin P, Crawford R et al. (2009). Is close follow up feasible for high-risk cervical premalignant lesion in developing countries? Author's reply. nameOfConference

  
  

  DOI: 10.1111/j.1471-0528.2008.02019.x

  
  

  QMRO: qmroHref
• Manchanda R, Jacobs IJ (2009). Screening and prevention of gynaecological cancers. nameOfConference

  
  

  DOI: 10.1017/CBO9780511691799.003

  
  

  QMRO: qmroHref
• Manchanda R, Menon U (2008). Serum markers for gynaecological cancer in the reproductive years. nameOfConference

  
  

  DOI: 10.1017/cbo9781107786110.015

  
  

  QMRO: qmroHref
• Manchanda R, Baldwin P, Crawford R et al. (2008). Effect of margin status on cervical intraepithelial neoplasia recurrence following LLETZ in women over 50 years. nameOfConference

  
  

  DOI: 10.1111/j.1471-0528.2008.01853.x

  
  

  QMRO: qmroHref
• Manchanda R, Palep-Singh M, Prentice A (2008). Can uterine artery embolisation affect endometrial perfusion and function. nameOfConference

  
  

  DOI: 10.1080/01443610801967000

  
  

  QMRO: qmroHref
• Manchanda R, Kriplani A (2005). Giant malignant ovarian tumor: A case report. nameOfConference

  
  

  DOI: 10.1111/j.1525-1438.2005.00196.x

  
  

  QMRO: qmroHref
• Manchanda R, Sriemevan A (2005). Anaphylactoid syndrome caused by amniotic fluid embolism following manual removal of placenta. nameOfConference

  
  

  DOI: 10.1080/01443610500052013

  
  

  QMRO: qmroHref
• Manchanda R, Refaie A (2005). Acute pneumoperitoneum following coitus.. nameOfConference

  
  

  DOI: 10.1017/s148180350001294x

  
  

  QMRO: qmroHref
• Manchanda R, Varma R, Anya I et al. (2004). Representation of authors and editors from poor countries [1] (multiple letters). nameOfConference

  
  

  DOI: doi

  
  

  QMRO: qmroHref
• Manchanda R, Varma R (2004). Representation of authors and editors from poor countries: observed publication bias may reflect who is funding research.. nameOfConference

  
  

  DOI: 10.1136/bmj.329.7457.110

  
  

  QMRO: qmroHref
• Kriplani A, Agarwal N, Parul et al. (2003). Bilateral seminomas in a 45X/46XY mosaic with Turner's phenotype: An unusual case of mixed gonadal dysgenesis. nameOfConference

  
  

  DOI: 10.1046/j.1341-8076.2003.00028.x

  
  

  QMRO: qmroHref
• Kriplani A, Manchanda R, Nath J et al. (2002). A randomized trial of danazol pretreatment prior to endometrial resection. nameOfConference

  
  

  DOI: 10.1016/S0301-2115(02)00012-X

  
  

  QMRO: qmroHref
• Kriplani A, Manchanda R, Monga D et al. (2001). Depot medroxy progesterone acetate: A poor preparatory agent for endometrial resection. nameOfConference

  
  

  DOI: 10.1159/000052969

  
  

  QMRO: qmroHref
• Kriplani A, Agarwal N, Roy KK et al. (2001). Laparoscopic management of Sertoli-Leydig cell tumors of the ovary: A report of two cases. nameOfConference

  
  

  DOI: doi

  
  

  QMRO: qmroHref
• Kriplani A, Manchanda R, Agarwal N et al. (2001). Laparoscopic ovarian drilling in clomiphene citrate-resistant women with polycystic ovary syndrome. nameOfConference

  
  

  DOI: 10.1016/S1074-3804(05)60613-5

  
  

  QMRO: qmroHref

Supervision

Xia Wei: Decision Analysis and Economic Modelling for Ovarian Cancer Prevention. Funding: Rosetrees Trust and China Medical Board

Samuel Oxley: Prevention of Endometrial Cancer. Funding: Rosetrees Trust

Jyotsna Pundir: Role of Myo-inositol in Poly Cystic Ovary Syndrome. Funding: Self funded

Dhivya Chandrasekaran: Implementation of unselected germline and somatic genetic testing in epithelial ovarian cancer delivered through a cancer-multidisciplinary pathway. Funding: Barts Charity

Faiza Gaba: Targeted Prevention of Ovarian Cancer. Funding: Rosetrees Trust and Barts Charity